INVO reduces warrant exercise price to $2.85 for 276,000 shares after shareholder approval

INVO Fertility, Inc.

Amendment executed Dec 28, 2023 lowers exercise price from $12.60 to $2.85 per share for 276,000 shares.
Original warrant from March 2023 at $0.63 per share adjusted after 1-for-20 reverse split in July 2023.
Reduction aligns with per-unit price of $2.85 from August 2023 public offering, previously agreed in SPA Amendment.
Shareholder approval obtained at Dec 26, 2023 Annual Meeting per Nasdaq Listing Rule 5635(d).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. amended Amendment to Common Stock Purchase Warrant with a certain institutional investor (effective 2023-12-28).

Action: amendment
Agreement: equity purchase
Counterparty: a certain institutional investor
Effective: 2023-12-28

Exact text from the filing

On December 28, 2023, INVO Bioscience, Inc. (the “Company”) entered into an Amendment to Common Stock Purchase Warrant (the “Amendment”) with s certain institutional investor to amend that certain Common Stock Purchase Warrant dated March 27, 2023 issued by the Company to such investor (the “Original Warrant”) to reduce the exercise price under Section 2(b) thereunder to $2.85 per share.

View on SEC.gov

268 material agreements filed in the last 30 days. Browse all material agreements →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-046392

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.